Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-791-1 | CAS number: 5080-22-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was not conducted according to guidelines but was conducted according to GLPs and the report contains sufficient data for interpretation of study results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 986
- Report date:
- 1986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Report does not specifically state that it followed a guideline but method used suggests that it is equivalent or similar to OECD 401.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- N-isopropylhydroxylamine
- EC Number:
- 225-791-1
- EC Name:
- N-isopropylhydroxylamine
- Cas Number:
- 5080-22-8
- Molecular formula:
- C3H9NO
- IUPAC Name:
- N-(propan-2-yl)hydroxylamine
- Details on test material:
- Test material identified as N-Isopropylhydroxylamine. No additional information available.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Young adult male and female Sprague-Dawley rats were obtained from Charles River Breeding Laboratories, lnc., Wilminton, MA for use in this study.
All housing and care conformed to the standards established in the "Guide for the Care ane Use of Laboratory Animals" DHEW," Publication No. (NIH)
85-23. Animals were individually housed in wire mesh bottom cages in environment-controlled rooms and provided NIH O7 Open Formula, certified feed (Zeigler Brothers, lnc., Gardners, Ph) and water ad libitum. After an acclimation period of at least 5 days, animals were assigned to the test. Animals were examinee daily during acclimation to assure their suitability as test animals.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- Based on the results of the trial test; one dose level at 5.0. g/kg body weight administered to each of ten rats it was decided to define the LC50 value. A range finding study was conducted to deterrnine dose level s for the main study . On the first day of the study, animals received a single oral dose by gavage of the test article administered at a constant concentration.
- Doses:
- For the Trial Test, groups of 5 males and 5 females were dosed with 5000 mg/kg.
For the Range Finding Study, groups of two males and two females were dosed with 250, 484, 935, 1809 and 3500 mg/kg.
For the definitive LC50 study, groups of 5 male and 5 female rats were dosed with 1500, 2027, 2739, 3700 and 5000 mg/kg. - No. of animals per sex per dose:
- 5 males and 5 females for the definitive LC50 study.
- Control animals:
- not specified
- Details on study design:
- For the definitive LD50 study, groups of 5 males and 5 females were dosed orally with specified doses of test material. All animals were observed for 14 days after dosing. Rats were observed daily during the 14 day observation period. All survivng rats were weighed on day 1, 8 and 15 (with day 1 being the day of dosing). All animals that died during the observation period as well as animals that survived the 14 day observation period were subjected to a gross pathologic examination.
- Statistics:
- The LD50 values with 95% confidence limits and the slopes of the response curves were calculated using probit analysis (Finney, D.J., Statistical Methods in Biological Assay, secone edition. London: Griffin Press, 1971) when possible, otherwise an alternative acceptable method will be used and documented.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2 356 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 887 - <= 2 825
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 942 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 560 - <= 2 315
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 189 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 871 - <= 2 507
- Mortality:
- Trial Test (5000 mg/kg): all animals died one day after dosing.
In the Range Finding Study, two of four rats (sex not specified) died on the first day after dosing. No other deaths were observed over an 8 day observation period at dose levels ranging from 250 -3500 mg/kg.
In the Definitive LD50 study, 5 of 5 male rats dosed with 3700 or 5000 mg/kg died on day 1 or 2 after dosing. At 2739 mg/kg, 4 of 5 male rats died on day 2 after dosing. At 2027 mg/kg, one of 5 male rats died two days after dosing. All male animals in the 1500 mg/kg group survived the 14 day obseration period. In the same study 5 of 5 female rats dosed at 2739, 3700 or 5000 mg/kg died on day 1 or 2 after dosing. At 2027 mg/kg, four of 5 female rats died on day 2 post dosing. At 1500 mg/kg, all female rats survived the 14 day observation period. - Clinical signs:
- other: In the definitive LD50 study, ataxia, decreased activity and increased respiratory rate were the most common clinical observations. Others included salivation, lacrimation, wet abdomen and dark material around the nose. Similar response was noted at hig
- Gross pathology:
- In the lowest dose level were most of the animals died during the observation period, 2027 and 2739 mg/kg, dark red areas or spots of the lung were the most common observation upon gross necropsy examination. Similar findings were made at higher doses,
There were no noteworthy findings in the 1500 mg/kg group of male or female rats. - Other findings:
- No additional information available.
Any other information on results incl. tables
No additional information available.
Applicant's summary and conclusion
- Conclusions:
- The LD50 for male rats was calculated to be 2356 mg/kg body weight with a 95% confidence interval of 1887 to 2825 mg/kg. The LD50 for females was calculated to be 1942 mg/kg with a 95% confidence interval of 1569 to 2315 mg/kg and the combined response was calculated to be 2189 mg/kg with a 95% confidence interval of 1871 to 2507 mg/kg.
- Executive summary:
The purpose of this study was to determine the acute oral LD50 of N-Isopropylhydroxylamine following administration by gavage to male and female Sprague-Dawley rats.
The LD50 for male rats was calculated to be 2356 mg/kg body weight with a 95% confidence interval of 1887 to 2825 mg/kg. The LD50 for females was calculated to be 1942 mg/kg with a 95% confidence interval of 1569 to 2315 mg/kg and the combined response was calculated to be 2189 mg/kg with a 95% confidence interval of 1871 to 2507 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.